Cannabiz and Prohibition Partners join forces to launch Oceania report by Martin Lane November 14, 2023November 14, 2023 Cannabiz has joined forces with Prohibition Partners to bring the cannabis data and intelligence firm’s Oceania […]
Number of clinical trials using cannabis ‘exploded’ in last decade by Martin Lane September 1, 2023September 1, 2023
Caution, optimism and frustration: the mixed, uncertain picture of the European cannabis industry by Steve Jones July 14, 2022July 15, 2022
Italy supply woes continue as industry renews call to open up to imports by Steve Jones July 5, 2022July 7, 2022
UK must reform or miss the economic benefits of cannabis, research finds by Steve Jones June 23, 2022June 23, 2022
Prohibition Partners report identifies two key industry trends by Hannah Adler September 15, 2021September 15, 2021
Report finds sales of three major cannabis pharmaceutical products set to reach EU$1.8 billion by 2025 by Hannah Adler September 6, 2021September 8, 2021
Prohibition Partners snaps up North American media platform Business of Cannabis by Martin Lane August 6, 2021August 11, 2021
‘Celebrity endorsements drive shareholder value, but they must be authentic’ by Martin Lane May 25, 2021August 14, 2023
‘It’s all medicinal’: more research needed for cannabis to maximise health and wellness opportunity by Martin Lane May 24, 2021May 26, 2021
